Excite Pharma Services — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Excite Pharma Services is a private, revenue-generating contract development and manufacturing organization (CDMO) and contract research organization (CRO) founded in 2010 and headquartered in New York, USA. The company provides end-to-end CMC services, including analytical chemistry, method development/validation, stability testing, and aseptic manufacturing for both clinical and commercial supply. Its business model is purely service-based, catering to pharmaceutical clients without an internal therapeutic pipeline, and it differentiates itself through a strong compliance focus and a client-centric operational philosophy.

Drug DeliveryDigital Health

Technology Platform

Integrated CMC service platform specializing in analytical chemistry (method development/validation, stability, E&L testing) and aseptic manufacturing under cGMP/GLP standards.

Opportunities

The growing trend of pharmaceutical outsourcing, especially for complex sterile injectables, presents a significant opportunity.

The company's US-based, FDA-compliant facility is a key asset for sponsors seeking to mitigate supply chain risk.

Rising demand from virtual and small biotech companies lacking internal CMC capabilities provides a expanding client base.

Risk Factors

Intense competition from larger global CDMOs and niche players creates pricing and margin pressure.

Revenue is project-based and can be volatile.

The core business is highly sensitive to regulatory compliance; a significant FDA audit failure could severely damage reputation and operations.

Competitive Landscape

Excite Pharma competes in the fragmented but competitive CDMO/CRO market. It faces competition from large, full-service global CDMOs (e.g., Lonza, Catalent), specialized aseptic fill-finish providers, and numerous regional and niche analytical service labs. Its differentiation hinges on a focused service mix, regulatory compliance, and a client-centric culture.

More companies in Digital Health & Biotech SaaS →More companies in United States →